Analysts who follow Vascular Biogenics Ltd (VBLT) on average expect it to climb 253.92% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns the stock an Analyst Ranking of 74, which means it ranks higher than 74 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating VBLT a Strong Buy today. Find out what this means to you and get the rest of the rankings on VBLT!